Quarterly report pursuant to Section 13 or 15(d)

Note 7 - STOCKHOLDERS' DEFICIT (Details) - Share-based Compensation, Stock Options, Activity

v3.19.1
Note 7 - STOCKHOLDERS' DEFICIT (Details) - Share-based Compensation, Stock Options, Activity - USD ($)
3 Months Ended 12 Months Ended
Jan. 25, 2019
Jan. 14, 2019
Mar. 31, 2019
Dec. 31, 2018
Share-based Compensation, Stock Options, Activity [Abstract]        
Balance Outstanding, Number of Shares     1,800,000 0
Balance Outstanding, Weighted Average Exercise Price     $ 0  
Balance Outstanding, Weighted Average Remaining Contractual Term     9 years 295 days  
Balance Outstanding, Aggregate Intrinsic Value     $ 0  
Exercisable, Number of Shares       0
Exercisable, Weighted Average Exercise Price     $ 0  
Exercisable, Weighted Average Remaining Contractual Term     0 years  
Exercisable, Aggregate Intrinsic Value     $ 0  
Granted, Number of Shares 800,000     1,800,000
Granted, Weighted Average Exercise Price $ 0.75 $ 0.75 $ 0.75  
Granted, Weighted Average Remaining Contractual Term     10 years  
Balance Outstanding, Number of Shares       1,800,000
Balance Outstanding, Weighted Average Exercise Price     $ 0.75 $ 0
Balance Outstanding, Aggregate Intrinsic Value     $ 0 $ 0